Burjeel Medical City – Abu Dhabi, United Arab Emirates
Burjeel Medical City (BMC), located in Mohammed Bin Zayed City, Abu Dhabi, is one of the most advanced and comprehensive tertiary care hospitals in the Middle East. Operated by Burjeel Holdings (formerly VPS Healthcare), it serves as the group’s flagship quaternary medical complex, providing world-class multidisciplinary healthcare, clinical research, and medical education. Burjeel Medical City is internationally recognized for its specialized centers of excellence in oncology, organ transplantation, advanced surgery, and rehabilitation.
• Accreditation and Standards:
Burjeel Medical City is accredited by the Joint Commission International (JCI) and certified by ISO 9001:2015 for quality management and patient safety. It operates under the Department of Health – Abu Dhabi (DOH) and maintains partnerships with leading global healthcare institutions to uphold the highest standards of clinical excellence, ethics, and innovation.
• Infrastructure and Capacity:
• A 1.2 million square-foot medical complex housing a 400-bed tertiary and quaternary care hospital.
• 14 specialized operating theatres, ICU and NICU units, and 24/7 emergency and trauma services.
• Comprehensive diagnostic imaging and nuclear medicine departments, including 3 Tesla MRI, PET-CT, and digital mammography.
• Integrated radiation oncology center with linear accelerators and brachytherapy technology.
• Transplant and advanced surgery units, fully equipped for multi-organ transplants.
• Rehabilitation and long-term care facility, offering advanced physical, occupational, and speech therapy services.
• VIP inpatient suites and luxury patient accommodation designed to combine comfort and privacy.
• Centers of Excellence and Key Specialties:
• Oncology and Hematology: Comprehensive cancer center providing chemotherapy, radiotherapy, and surgical oncology services, supported by precision diagnostics and molecular medicine.
• Transplant Medicine: Multiorgan transplantation including liver, kidney, and bone marrow transplants.
• Cardiac Sciences: Interventional cardiology, cardiac surgery, and rehabilitation programs.
• Neurosciences: Neurology, neurosurgery, and neurorehabilitation with advanced imaging and intraoperative monitoring.
• Orthopedics and Spine Surgery: Robotic-assisted joint replacement, trauma management, and spine correction.
• Pediatrics and Neonatology: Comprehensive pediatric subspecialties, including oncology, neurology, and intensive neonatal care (Level 3 NICU).
• Obstetrics and Gynecology: High-risk pregnancy management, fetal medicine, and advanced gynecologic surgery.
• Gastroenterology and Hepatology: Endoscopy, colonoscopy, and minimally invasive liver and digestive system procedures.
• Urology and Nerology:Dialysis, lithotripsy, endourology, and renal transplant support.
• Plastic and Reconstructive Surgery: Cosmetic and reconstructive procedures following trauma, burns, or cancer treatment.
• Endocrinology and Diabetes: Specialized care for metabolic, hormonal, and autoimmune disorders.
• Technology and Innovation:
Burjeel Medical City integrates AI-based diagnostic imaging, robotic-assisted surgical systems, and electronic health records (EHR). It features smart ICU monitoring, telemedicine connectivity, and precision oncology platforms utilizing genomic and molecular profiling to tailor patient treatment plans.
• Research and Education:
As a center for academic medicine, Burjeel Medical City collaborates with international universities and research institutes. It houses a Clinical Research Department and offers Continuing Medical Education (CME) programs, medical residencies, and clinical training for healthcare professionals.
• International Patient Services:
Burjeel Medical City is a major destination for medical tourism and advanced treatment referrals, serving patients from Iraq, the Kurdistan Region, Africa, Europe, and South Asia. Its International Patient Care Department provides:
• Comprehensive visa and travel coordination.
• Airport transfers and accommodation assistance.
• Multilingual interpreters and cultural liaison officers.
• Personalized case management and transparent financial packages.
• Teleconsultation and long-term follow-up care after treatment.
Diva Health Access – Strategic Partnership with MediGence Global
Through the Diva Health Access Strategic Partnership with MediGence Global, Burjeel Medical City enhances its international medical access for patients from Iraq and the Kurdistan Region, offering seamless pathways to specialized and complex treatments in the UAE.
This partnership enables:
• Virtual multidisciplinary case reviews and pre-treatment consultations with leading specialists.
• End-to-end coordination for travel, medical visas, and hospital admission.
• Collaborative clinical and academic programs in oncology, organ transplantation, and advanced surgery.
• Commitment to transparent, ethical, and internationally benchmarked healthcare standards.
This collaboration reinforces Diva Health’s mission to connect Iraq and Kurdistan with globally accredited centers of medical excellence—delivering innovation, integrity, and hope through Burjeel Medical City, Abu Dhabi, United Arab Emirates.